Medizinische Klinik und Poliklinik II, Abt. Hamatologie und Onkologie
Leipzig, Germany
University hospital in Leipzig, Saxony
Liebigstr. 20 (Haus 4) und 22 (Haus 7, Johannisallee 32A/Haus 9, 04103 Leipzig
About Medizinische Klinik und Poliklinik II, Abt. Hamatologie und Onkologie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Medizinische Klinik und Poliklinik II, Abt. Hamatologie und Onkologie
During the past decade, Medizinische Klinik und Poliklinik II, Abt. Hamatologie und Onkologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM)
2010-08-01
2012-05-01
Completed
161
Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer
2011-12-30
2023-03-31
Active, not recruiting
530
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Medizinische Klinik und Poliklinik II, Abt. Hamatologie und Onkologie"
#1 collaborator was "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Medizinische Klinik und Poliklinik II, Abt. Hamatologie und Onkologie
According to Clinical.Site data, the most researched conditions in "Medizinische Klinik und Poliklinik II, Abt. Hamatologie und Onkologie" are
"Acute Myelogenous Leukemia" (1 trials), "Aspergillosis" (1 trials), "Candidiasis" (1 trials), "Essential Thrombocythemia (ET)" (1 trials) and "Myelodysplastic Syndrome" (1 trials). Many other conditions were trialed in "Medizinische Klinik und Poliklinik II, Abt. Hamatologie und Onkologie" in a lesser frequency.
Clinical Trials Intervention Types at Medizinische Klinik und Poliklinik II, Abt. Hamatologie und Onkologie
Most popular intervention types in "Medizinische Klinik und Poliklinik II, Abt. Hamatologie und Onkologie" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "FK463" (2 trials), "Azacitidine" (1 trials), "BAT" (1 trials), "Emavusertib" (1 trials) and "Ruxolitinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Medizinische Klinik und Poliklinik II, Abt. Hamatologie und Onkologie
The vast majority of trials in "Medizinische Klinik und Poliklinik II, Abt. Hamatologie und Onkologie" are
4 trials for "All" genders.
Clinical Trials Status at Medizinische Klinik und Poliklinik II, Abt. Hamatologie und Onkologie
Currently, there are NaN active trials in "Medizinische Klinik und Poliklinik II, Abt. Hamatologie und Onkologie".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Medizinische Klinik und Poliklinik II, Abt. Hamatologie und Onkologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Medizinische Klinik und Poliklinik II, Abt. Hamatologie und Onkologie, 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".